Literature DB >> 9886438

Gene therapy of experimental autoimmune thyroiditis by in vivo administration of plasmid DNA coding for Fas ligand.

F Batteux1, L Tourneur, H Trebeden, J Charreire, G Chiocchia.   

Abstract

Fas-Fas ligand (FasL) interaction is required for the maintenance of immune homeostasis and seems to be responsible for the privileged immune status of some tissues. Experimental autoimmune thyroiditis (EAT), which is characterized by autoreactive T and B cell responses and a marked lymphocytic infiltration of the thyroid, is a model of choice to study the therapeutic effects of FasL. Here, we provide evidence that direct injection of DNA expression vectors encoding FasL into the inflamed thyroid inhibited development of lymphocytic infiltration of the thyroid and induced death of infiltrating T cells. These results were paralleled by a total abrogation of anti-Tg cytotoxic T cell response in FasL-treated animals vs controls. In summary, our results show that FasL expression on thyrocytes may have a curative effect on ongoing EAT by inducing death of pathogenic autoreactive infiltrating T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9886438

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

Review 1.  The role of apoptosis in autoimmune thyroid disorders and thyroid cancer.

Authors:  J D Lin
Journal:  BMJ       Date:  2001-06-23

2.  Pancreatic islets engineered with a FasL protein induce systemic tolerance at the induction phase that evolves into long-term graft-localized immune privilege.

Authors:  Kyle B Woodward; Hong Zhao; Pradeep Shrestha; Lalit Batra; Min Tan; Orlando Grimany-Nuno; Laura Bandura-Morgan; Nadir Askenasy; Haval Shirwan; Esma S Yolcu
Journal:  Am J Transplant       Date:  2020-01-05       Impact factor: 8.086

3.  Fas/FasL mediated apoptosis of thyrocytes in Graves' disease.

Authors:  N Sera; A Kawakami; T Nakashima; H Nakamura; M Imaizumi; T Koji; Y Abe; T Usa; T Tominaga; E Ejima; K Ashizawa; N Yokoyama; N Ishikawa; K Ito; K Eguchi
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

4.  Experimental study of local inner ear gene therapy for controlling autoimmune sensorineural hearing loss.

Authors:  Chang-qiang Tan; Xia Gao; Wen-jun Cai; Xiao-yun Qian; Ling Lu; He Huang
Journal:  Biomed Res Int       Date:  2014-04-07       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.